287 related articles for article (PubMed ID: 25200454)
21. Paracetamol toxicity: what would be the implications of a change in Australian treatment guidelines?
Wong A; Graudins A; Kerr F; Greene SL
Emerg Med Australas; 2014 Apr; 26(2):183-7. PubMed ID: 24708009
[TBL] [Abstract][Full Text] [Related]
22. Changing nomogram risk zone classification with serial testing after acute acetaminophen overdose: a retrospective database analysis.
Mutsaers A; Green JP; Sivilotti MLA; Yarema MC; Tucker D; Johnson DW; Spyker DA; Rumack BH
Clin Toxicol (Phila); 2019 Jun; 57(6):380-386. PubMed ID: 30689438
[TBL] [Abstract][Full Text] [Related]
23. Paracetamol (acetaminophen) poisoning: The early years.
Prescott LF
Br J Clin Pharmacol; 2024 Jan; 90(1):127-134. PubMed ID: 37683599
[TBL] [Abstract][Full Text] [Related]
24. Analysis of an 8-hour acetylcysteine infusion protocol for repeated supratherapeutic ingestion (RSTI) of paracetamol.
Wong A; Gunja N; McNulty R; Graudins A
Clin Toxicol (Phila); 2018 Mar; 56(3):199-203. PubMed ID: 28812380
[TBL] [Abstract][Full Text] [Related]
25. Retrospective evaluation of repeated supratherapeutic ingestion (RSTI) of paracetamol
Egan H; Isbister GK; Robinson J; Downes M; Chan BS; Vecellio E; Chiew AL
Clin Toxicol (Phila); 2019 Aug; 57(8):703-711. PubMed ID: 30789042
[No Abstract] [Full Text] [Related]
26. Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds.
Beer C; Pakravan N; Hudson M; Smith LT; Simpson K; Bateman DN; Thomas SH
QJM; 2007 Feb; 100(2):93-6. PubMed ID: 17237484
[TBL] [Abstract][Full Text] [Related]
27. Hepatotoxicity after paracetamol overdose in a patient with cystic fibrosis despite early acetylcysteine and utility of microRNA to predict hepatotoxicity.
Wong A; Cheung B; Nejad C; Gantier M; Graudins A
Clin Toxicol (Phila); 2018 Oct; 56(10):904-906. PubMed ID: 29564929
[TBL] [Abstract][Full Text] [Related]
28. Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury.
Schmidt LE; Knudsen TT; Dalhoff K; Bendtsen F
Lancet; 2002 Oct; 360(9340):1151-2. PubMed ID: 12387966
[TBL] [Abstract][Full Text] [Related]
29. Metabolic and mitochondrial treatments for severe paracetamol poisoning: a systematic review.
Mullins ME; Yeager LH; Freeman WE
Clin Toxicol (Phila); 2020 Dec; 58(12):1284-1296. PubMed ID: 32762579
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology, management and outcome of paracetamol poisoning in an inner city emergency department.
Carroll R; Benger J; Bramley K; Williams S; Griffin L; Potokar J; Gunnell D
Emerg Med J; 2015 Feb; 32(2):155-60. PubMed ID: 24099830
[TBL] [Abstract][Full Text] [Related]
31. Overdose with modified-release paracetamol (Panadol Osteo®) presenting to a metropolitan emergency medicine network: a case series.
Graudins A
Emerg Med Australas; 2014 Aug; 26(4):398-402. PubMed ID: 24934700
[TBL] [Abstract][Full Text] [Related]
32. Large paracetamol overdose-Higher dose acetylcysteine is required.
Bateman DN
Br J Clin Pharmacol; 2023 Jan; 89(1):34-38. PubMed ID: 34957591
[TBL] [Abstract][Full Text] [Related]
33. Paracetamol overdose: the liver unit perspective.
Iqbal M; Cash WJ; Sarwar S; McCormick PA
Ir J Med Sci; 2012 Sep; 181(3):439-43. PubMed ID: 22072400
[TBL] [Abstract][Full Text] [Related]
34. Hepatotoxicity in a child following an accidental overdose of liquid paracetamol.
Chiew AL; Domingo G; Buckley NA; Stathakis P; Ress K; Roberts DM
Clin Toxicol (Phila); 2020 Nov; 58(11):1063-1066. PubMed ID: 32067495
[No Abstract] [Full Text] [Related]
35. Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial.
; Dear J
Trials; 2019 Jan; 20(1):27. PubMed ID: 30621764
[TBL] [Abstract][Full Text] [Related]
36. Paracetamol overdose in the newborn and infant: a life-threatening event.
Locci C; Cuzzolin L; Capobianco G; Antonucci R
Eur J Clin Pharmacol; 2021 Jun; 77(6):809-815. PubMed ID: 33388821
[TBL] [Abstract][Full Text] [Related]
37. Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies.
Dear JW; Clarke JI; Francis B; Allen L; Wraight J; Shen J; Dargan PI; Wood D; Cooper J; Thomas SHL; Jorgensen AL; Pirmohamed M; Park BK; Antoine DJ
Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):104-113. PubMed ID: 29146439
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning.
Yarema MC; Johnson DW; Berlin RJ; Sivilotti ML; Nettel-Aguirre A; Brant RF; Spyker DA; Bailey B; Chalut D; Lee JS; Plint AC; Purssell RA; Rutledge T; Seviour CA; Stiell IG; Thompson M; Tyberg J; Dart RC; Rumack BH
Ann Emerg Med; 2009 Oct; 54(4):606-14. PubMed ID: 19556028
[TBL] [Abstract][Full Text] [Related]
39. Delays during the administration of acetylcysteine for the treatment of paracetamol overdose.
Bailey GP; Najafi J; Elamin ME; Waring WS; Thomas SH; Archer JR; Wood DM; Dargan PI
Br J Clin Pharmacol; 2016 Nov; 82(5):1358-1363. PubMed ID: 27412926
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic modelling of modified acetylcysteine infusion regimens used in the treatment of paracetamol poisoning.
Wong A; Landersdorfer C; Graudins A
Eur J Clin Pharmacol; 2017 Sep; 73(9):1103-1110. PubMed ID: 28624886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
